Colt Ventures

Total investments

11

Average round size

78M

Portfolio companies

10

Rounds per year

0.38

Lead investments

3

Follow on index

0.09

Exits

3

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsWellnessLife SciencePharmaceuticalTherapeuticsBiopharmaContent DiscoveryEmergency Medicine

Summary

Colt Ventures appeared to be the VC, which was created in 1995. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Dallas.

The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The increased amount of exits for fund were in 2018. The important activity for fund was in 2017.

We also calculated 1 valuable employee in our database.

The typical case for the fund is to invest in rounds with 3 participants. The meaningful sponsors for the fund in investment in the same round are City Hill Ventures, Silicon Valley Bank, RBV Capital. In the next rounds fund is usually obtained by Silicon Valley Bank, City Hill Ventures.

The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the most successful fund investment fields, there are Biotechnology, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight Ignyta, Bonti.

Show more

Investments analytics

Analytics

Total investments
11
Lead investments
3
Exits
3
Rounds per year
0.38
Follow on index
0.09
Investments by industry
  • Biotechnology (7)
  • Health Care (5)
  • Biopharma (5)
  • Pharmaceutical (4)
  • Therapeutics (3)
  • Show 17 more
Investments by region
  • United States (10)
  • Canada (1)
Peak activity year
2020
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
190M
Group Appearance index
1.00
Avg. company exit year
4
Avg. multiplicator
3.89

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Alterome Therapeutics 03 Apr 2024 Pharmaceutical, Biopharma Early Stage Venture 132M United States, California, San Diego

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.